Clinical trial sponsors working in oncology, hematology, IBD, infectious diseases, multiple sclerosis, and many rare diseases, rely on PSI’s guidance and experience, knowing we’re specialized and committed to delivering some of the most complex clinical projects in the industry.
Core Therapeutic Areas
Inflammatory Bowel Diseases (IBD)
Crohns’ Disease, Ulcerative Colitis, and other IBDs.
Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Ovarian Cancer, and other Oncology indications.
Multiple Myeloma, Lymphomas, Leukemias, and other oncohematological indications.
Antimicrobial and Antifungal infections and other ID.
Multiple Sclerosis, Spasticity, and other neurological indications.
Hemophilia A & B, Von Willebrand Disease, Thrombocytopenia, Polycythemia Vera, Paroxysmal Nocturnal Hemoglobinuria (PNH).
The PSI Advantage
PSI was flexible to meet the various challenges in clinical trial conduct. The rapid enrollment of patients and the quick study close out allowed on-time study completion.
Chief Medical Officer